Fresenius | FRE - Selling And Administration Expenses



Fresenius reported EUR740M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Akzo Nobel EUR 826M 29M Jun/2025
Alcon AG USD 870M 57M Jun/2025
AstraZeneca USD 5.01B 1.42B Jun/2025
BASF EUR 2.58B 67M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Beiersdorf EUR 322M 1.68B Jun/2025
DaVita Healthcare Partners USD 412.8M 38.71M Jun/2025
Demant DKK 5.95B 319M Jun/2025
E.ON EUR -1713000000 3.63B Jun/2025
Essilor EUR 1.09B 2.08B Jun/2025
Fresenius EUR 740M 97M Jun/2025
Fresenius Medical Care EUR 792M 41M Jun/2025
Getinge SEK 2.65B 452M Dec/2024
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.14B 80M Jun/2025
GN Store Nord DKK 1.42B 101M Jun/2025
GRIFOLS EUR 282.76M 41.9M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
Merck EUR 1.48B 9M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Philips EUR 1.24B 9M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
RWE EUR 690M 84M Mar/2025
Sanofi EUR 2.63B 408M Jun/2025
Smith & Nephew USD 1.42B 77.8M Jun/2025